Seen in the press: Nemera’s article featured in October ‘Prefilled Syringes & Injection Devices’

NEMERA NEWS

‘Prefilled Syringes & Injection Devices’ magazine features Nemera’s article about the pain perception in relation to injectable drug delivery.

The recently published ‘Prefilled Syringes & Injection Devices’ magazine includes an article from Nemera:  “Injection devices and pain perception”.

In this article, Severine Duband, Category Manager, Nemera, discusses the issue of patient comfort and pain perception in relation to injectable drug delivery and how the features of Nemera’s two-step autoinjector, Safelia®, help take on this challenge.

In today’s healthcare world, there is an ever-increasing emphasis on patient-centricity. A key aspect of this is pain perception; in order to be truly patient-centric, we must seek to minimize the pain experienced by the patient. With the shift towards moving healthcare out of the clinical setting and into the home as much as possible, designing devices with minimal pain perception becomes important than ever before, as it has a direct impact on a patient’s willingness to administer their prescribed treatment.

 

The article is based on a presentation given by Séverine Duband at SMi’s Prefilled Syringes West Coast Conference in San Diego, CA, US on June 4, 2018.


The full article:

The full issue of the magazine:


About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.

Nemera’s services and products cover several key delivery routes: Ophthalmic, Nasal, Buccal, Auricular, Inhalation, Dermal/Transdermal and Parenteral.

Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and customer IP manufacturing.
.

Share